International Clinical Trial: Multi-omics Study on the Pathogenesis of Rheumatic Diseases: An Integrated Exploration Based on Immunogenetics and Gut Microbiome

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128476) titled 'Multi-omics Study on the Pathogenesis of Rheumatic Diseases: An Integrated Exploration Based on Immunogenetics and Gut Microbiome' on July 21.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The First People's Hospital of Lianyungang

Condition: Rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, systemic sclerosis, Sjogren's syndrome.

Intervention: Experimental group:None Experimental group:None Experimental group:None Experimental group:No intervention measures. control group.:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enr...